These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
676 related articles for article (PubMed ID: 2488874)
1. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria. Lim HW Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874 [TBL] [Abstract][Full Text] [Related]
2. Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study. Timonen K; Kariniemi AL; Niemi KM; Teppo AM; Tenhunen R; Kauppinen R J Am Acad Dermatol; 2000 Sep; 43(3):489-97. PubMed ID: 10954661 [TBL] [Abstract][Full Text] [Related]
3. Activation of the complement system in patients with porphyrias after irradiation in vivo. Lim HW; Poh-Fitzpatrick MB; Gigli I J Clin Invest; 1984 Dec; 74(6):1961-5. PubMed ID: 6392339 [TBL] [Abstract][Full Text] [Related]
4. [Comparative morphological studies on porphyria cutanea tarda and erythropoietic protoporphyris]. Kint A; De Weert J Hautarzt; 1978 Apr; 29(4):198-204. PubMed ID: 649396 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietic protoporphyria. Photoactivation of the complement system. Gigli I; Schothorst AA; Soter NA; Pathak MA J Clin Invest; 1980 Sep; 66(3):517-22. PubMed ID: 7400327 [TBL] [Abstract][Full Text] [Related]
6. Porphyria: genetic and acquired. Cripps DJ IARC Sci Publ; 1986; (77):549-66. PubMed ID: 3298037 [TBL] [Abstract][Full Text] [Related]
8. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias. Grossman ME; Poh-Fitzpatrick MB Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900 [TBL] [Abstract][Full Text] [Related]
9. Porphyria cutanea tarda as the most common porphyria. Bulat V; Lugović L; Situm M; Buljan M; Bradić L Acta Dermatovenerol Croat; 2007; 15(4):254-63. PubMed ID: 18093456 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of protoporphyrin and uroporphyrin on murine mast cells. Lim HW; Gigli I; Wasserman SI J Invest Dermatol; 1987 Mar; 88(3):281-6. PubMed ID: 3102621 [TBL] [Abstract][Full Text] [Related]
11. Mast cells and transforming growth factor-beta expression: a possible relationship in the development of porphyria cutanea tarda skin lesions. Lançoni G; Ravinal RC; Costa RS; Roselino AM Int J Dermatol; 2008 Jun; 47(6):575-81. PubMed ID: 18477147 [TBL] [Abstract][Full Text] [Related]
12. Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda. Lim HW; Perez HD; Poh-Fitzpatrick M; Goldstein IM; Gigli I N Engl J Med; 1981 Jan; 304(4):212-6. PubMed ID: 7442746 [No Abstract] [Full Text] [Related]
15. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY. KOVAL A; DANBY CW; PETERMANN H Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652 [TBL] [Abstract][Full Text] [Related]
17. Porphyrin-induced photodamage as related to the subcellular localization of the porphyrins. Sandberg S; Romslo I; Høvding G; Bjørndal T Acta Derm Venereol Suppl (Stockh); 1982; 100():75-80. PubMed ID: 6962638 [TBL] [Abstract][Full Text] [Related]
18. [Sclerodermatous changes in porphyria cutanea tarda: six cases]. Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888 [TBL] [Abstract][Full Text] [Related]
19. Photosensitivity and cutaneous acid hydrolases in porphyria cutanea tarda. Volden G; Thune P Ann Clin Res; 1979 Aug; 11(4):129-32. PubMed ID: 517992 [TBL] [Abstract][Full Text] [Related]
20. Management of acute and cutaneous porphyrias. Badminton MN; Elder GH Int J Clin Pract; 2002 May; 56(4):272-8. PubMed ID: 12074210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]